fluorodeoxyglucose f18 has been researched along with palbociclib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diamond, T; Kumar, S | 1 |
| Boers, J; de Vries, EFJ; Elias, SG; Glaudemans, AWJM; Hospers, GAP; Kwee, TC; Martens, JWM; Schröder, CP; Schuuring, E; Venema, CM | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and palbociclib
| Article | Year |
|---|---|
Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Cyclin-Dependent Kinases; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Letrozole; Middle Aged; Neoplasm Metastasis; Outcome Assessment, Health Care; Piperazines; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Pyridines; Receptors, Estrogen; Young Adult | 2020 |
1 other study(ies) available for fluorodeoxyglucose f18 and palbociclib
| Article | Year |
|---|---|
Paraneoplastic syndrome - a rare but treatable cause of non-thyroid-related extraocular muscle enlargement.
Topics: Aged; Antigens, Neoplasm; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Diplopia; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Hypertrophy; Letrozole; Magnetic Resonance Imaging; Ocular Motility Disorders; Oculomotor Muscles; Paraneoplastic Syndromes; Piperazines; Positron-Emission Tomography; Prednisone; Pyridines | 2019 |